Stock

PTC Therapeutics, Inc. PTCT

$77.16-1.64%

All stocks Create account to unlock

Overview

PTCT market data

Price History

PTCT price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for PTCT. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

7 captured

Wells Fargo Maintains Overweight on PTC Therapeutics, Lowers Price Target to $93 · Jul 20, 2026, 12:38 PM

Cantor Fitzgerald Maintains Overweight on PTC Therapeutics, Raises Price Target to $130 · Jul 16, 2026, 11:46 AM

What This PTC Therapeutics Insider Sale Means as Product Revenue Hit $226 Million · Jul 14, 2026, 11:00 AM

RBC Capital Maintains Sector Perform on PTC Therapeutics, Raises Price Target to $85 · Jul 7, 2026, 3:50 PM

8-K filing — PTC THERAPEUTICS, INC. (PTCT) · Jun 16, 2026, 11:00 AM

PTC Therapeutics Announces Proposed Private Placement Of $500M Of Convertible Senior Notes Due 2031 · Jun 15, 2026, 11:20 AM

Jefferies Upgrades PTC Therapeutics to Buy, Raises Price Target to $85 · May 27, 2026, 4:00 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock